Create a free research account to view current pricing and place an order.
How does Pinealon work in research models?
Pinealon is a short bioregulator peptide researched for neuroprotective, pineal/circadian, and cognitive-support signaling. Clinical standardization remains limited.
What is the half-life of Pinealon?
Half-life: Not standardized.
Human pharmacokinetics are not standardized. Treat exposure as short acting unless compound-specific data or formal formulation labeling indicates otherwise.
Research dosing reference
1-3 mg daily in cognitive/longevity-oriented short courses.
Dose interpretation (U-100 units)
| Target dose | U-100 units |
|---|---|
| 1 mg | 20 units |
| 2 mg | 40 units |
| 3 mg | 60 units |
Units are concentration-specific - confirm against your actual reconstitution volume.
How is Pinealon reconstituted?
| Vial | Preferred reconstitution | Final concentration |
|---|---|---|
| 10 mg | 2 mL BAC Water | 0.050 mg/unit |
Injection timing
Often used earlier in the day or as part of short bioregulator cycles.
Beginner escalation
Begin at 1 mg to assess neuroactive response before moving upward.
Side-effect mitigation
Monitor headache, fatigue, sleep changes, or stimulation/sedation shifts.
Stack compatibility
Pairs with neuro/circadian bioregulators; keep protocols simple for interpretability.
Storage & stability
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically.
Protocol duration & reassessment
Bioregulator protocols are commonly structured as short courses. Reassess after 10-30 days and allow an off-interval before repeating unless a clinician-directed objective supports continuation.
Frequently asked questions
What is Pinealon and how is it studied?
Pinealon is a short bioregulator peptide researched for neuroprotective, pineal/circadian, and cognitive-support signaling. Clinical standardization remains limited. Pinealon is catalogued in the Cognitive / Neuro group of this reference and is studied in laboratory and in-vitro models only. Pinealon is listed in this reference for laboratory context only; nothing here describes use in a person or animal.
What is known about the half-life of Pinealon?
Reference half-life for Pinealon: not standardized. Human pharmacokinetics are not standardized. Treat exposure as short acting unless compound-specific data or formal formulation labeling indicates otherwise. Published pharmacokinetic figures come from research and clinical-literature contexts and are listed here as reference values for laboratory work only, not as guidance for any person or animal.
How is Pinealon stored?
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically. Lyophilized research peptides are generally kept cold, dry, and away from light, and reconstituted solutions are labeled with concentration and date. Follow the storage conditions documented for the specific lot you receive.
How is Pinealon reconstituted for laboratory work?
The reference reconstitution for the 10 mg vial is 2 mL BAC Water, which gives a concentration of about 5 mg/mL. Concentration equals peptide mass divided by diluent volume, so adding more liquid lowers the concentration. Add diluent slowly down the vial wall, swirl rather than shake, and confirm the arithmetic before preparing any research solution.
Is Pinealon FDA approved?
No. The research-grade Pinealon described here is an investigational, research-use-only material and is not an FDA-approved drug product. Where an approved pharmaceutical form of a compound exists, it is a separate prescription product. This reference is not medical advice, and the material is not for human or animal consumption.
Pinealon product overview · Pinealon cost · All research reference · Research guides
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration